DUSA Pharmaceuticals to Present at the 12th Annual BIO CEO & Investor Conference

Published February 2, 2010, 5:30 am, PR Newswire via Yahoo! Finance

FirstCall/ -- DUSA Pharmaceuticals, Inc.®  , a specialty pharmaceutical company focused primarily on the development and marketing of its Levulan® Photodynamic Therapy technology platform for the prevention and treatment of dermatological skin conditions, announced that Bob Doman, President and Chief Executive Officer, will present a corporate overview at the 12th Annual BIO CEO & Investor ...

Discover News | Full Story